EHA / 14th Congress / Program overview per day / Sunday Program

Clinical Trial Update

Plenary Sessions Hematology-in-Focus sessions Clinical Trial Update Simultaneous Sessions

CLINICAL TRIAL UPDATE
10:30 – 11:45, Hall 1

NEW DRUGS IN THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS

Chair: T Barbui (Ospedali Riuniti di Bergamo, Bergamo, Italy)

  • CEP701
    E Hexner (University of Pennsylvania, Philadelphia, USA)
  • TRIAL REPORT: INCB018424 AND XL019
    S Verstovsek (University of Texas MD Anderson Cancer Centre, Houston, USA)
  • ITF2357 AND OTHER HDAC INHIBITORS
    A Rambaldi (Ospedali Riuniti di Bergamo, Bergamo, Italy)
  • ALLOGENEIC TRANSPLANT UPDATE IN MYELOFIBROSIS
    N Kröger (University Hospital Hamburg, Hamburg, Germany)

 

 

[Print view ]